Skip to main content

Blue Shield of California to Cover CombiMatrix's Diagnostic Lab Services

NEW YORK (GenomeWeb News) – CombiMatrix today announced that Blue Shield of California has agreed to provide coverage for its diagnostic laboratory services.

The insurer is the third largest in California with more than 3 million members, according to CombiMatrix and combined with the Irvine, Calif.-based firm's existing Multiplan contract, more than 60 million covered lives now have access to CombiMatrix's services, it said.

"The BSCA contract not only increases patient access, but as importantly, facilitates streamlined reimbursement, further supporting the rapid growth of our company,” CombiMatrix President and CEO Mark McDonough said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.